161 related articles for article (PubMed ID: 12444208)
1. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
Zoja C; Corna D; Camozzi D; Cattaneo D; Rottoli D; Batani C; Zanchi C; Abbate M; Remuzzi G
J Am Soc Nephrol; 2002 Dec; 13(12):2898-908. PubMed ID: 12444208
[TBL] [Abstract][Full Text] [Related]
2. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
[TBL] [Abstract][Full Text] [Related]
3. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
[TBL] [Abstract][Full Text] [Related]
4. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
[TBL] [Abstract][Full Text] [Related]
5. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
Zoja C; Liu XH; Abbate M; Corna D; Schiffrin EL; Remuzzi G; Benigni A
Exp Nephrol; 1998; 6(2):121-31. PubMed ID: 9567218
[TBL] [Abstract][Full Text] [Related]
7. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
8. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.
Benigni A; Zoja C; Corna D; Zatelli C; Conti S; Campana M; Gagliardini E; Rottoli D; Zanchi C; Abbate M; Ledbetter S; Remuzzi G
J Am Soc Nephrol; 2003 Jul; 14(7):1816-24. PubMed ID: 12819241
[TBL] [Abstract][Full Text] [Related]
9. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
Benigni A; Tomasoni S; Gagliardini E; Zoja C; Grunkemeyer JA; Kalluri R; Remuzzi G
J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
[TBL] [Abstract][Full Text] [Related]
10. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis.
Kramer AB; van der Meulen EF; Hamming I; van Goor H; Navis G
Kidney Int; 2007 Mar; 71(5):417-24. PubMed ID: 17213874
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
Yamamoto M; Fukui M; Shou I; Wang LN; Sekizuka K; Suzuki S; Shirato I; Tomino Y
J Clin Lab Anal; 1997; 11(1):53-62. PubMed ID: 9021525
[TBL] [Abstract][Full Text] [Related]
12. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
Benigni A; Gagliardini E; Remuzzi A; Corna D; Remuzzi G
Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
Benigni A; Corna D; Maffi R; Benedetti G; Zoja C; Remuzzi G
Kidney Int; 1998 Aug; 54(2):353-9. PubMed ID: 9690201
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy.
Tang SC; Leung JC; Chan LY; Eddy AA; Lai KN
Kidney Int; 2008 Feb; 73(3):288-99. PubMed ID: 18033243
[TBL] [Abstract][Full Text] [Related]
19. Renal protective effects of blocking the intrarenal renin-angiotensin system.
Li J; Zhou C; Yu L; Wang H
Hypertens Res; 1999 Sep; 22(3):223-8. PubMed ID: 10515446
[TBL] [Abstract][Full Text] [Related]
20. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
